Dr Reddys launches heartburn OTC tablet in US
Dr Reddys launches heartburn OTC tablet in US

Dr Reddys launches heartburn OTC tablet in US

Gayathri Udyawar Article rating: 5.0

The pharma major launched omeprazole delayed-release tablets, 20 mg, an over-the-counter (OTC) equivalent of Prilosec OTC in the US market. This has helped the stock trade in the green in an otherwise volatile market on Tuesday.

Rupee down by 1.6 per cent, bonds skid
Rupee down by 1.6 per cent, bonds skid

Rupee down by 1.6 per cent, bonds skid

Aakash Makhija Article rating: 5.0
The rupee and bonds plunged as Reserve Bank of India Governor, Urjit Patel resigned post market hours on Monday, surprising many investors. Concerns about mixed results from crucial state elections also kept traders wary during Tuesday's trading session.
Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore.

Strides Pharma JV gets approval for anthelmintic tablets
Strides Pharma JV gets approval for anthelmintic tablets

Strides Pharma JV gets approval for anthelmintic tablets

Nidhi Jani Article rating: 5.0

Strides Pharma Science Limited's 50:50 JV Strides Vivimed has got USFDA approval for Albendazole Tablets on Tuesday. The US market for the said tablets is around US$100mn as per IQVIA MAT data.

KDDL acquires Swiss watch company Estima AG
KDDL acquires Swiss watch company Estima AG

KDDL acquires Swiss watch company Estima AG

Apurva Joshi Article rating: 3.2

The Board of Directors of KDDL Limited has approved the acquisition of Estima AG, a Swiss watch hands manufacturing company through its subsidiaries Pylania SA and special purpose vehicle Kamla International Holdings SA.

Market sentiment sours as Urjit exits
Market sentiment sours as Urjit exits

Market sentiment sours as Urjit exits

Gayathri Udyawar Article rating: 5.0

The RBI Governor Urjit Patel tended his resignation on Monday ahead of the crucial board meeting scheduled for Friday, December 14. Also, the state election results will bring more volatility to the Indian equity markets.

Index trend and stocks in action December 11, 2018
Index trend and stocks in action December 11, 2018

Index trend and stocks in action December 11, 2018

Karan Dsij Article rating: 5.0

The level of 10,360 is likely to act as a strong support for the index as it is 61.8 per cent retracement level. Stocks in news: Wipro, Lupin, Zensar Technologies, Titagarh Wagons, KDDL, GMR Infrastructure, Cox & Kings, ICICI Bank and SBI.

Markets to open gap-down following RBI governor's sudden exit
Markets to open gap-down following RBI governor's sudden exit

Markets to open gap-down following RBI governor's sudden exit

Karan Dsij Article rating: 5.0

Indian markets stares at a major gap-down start on Tuesday as in a surprise move, the RBI governor Dr Urjit Patel submitted his resignation with immediate effect. Dr Patel has cited personal reasons for his resignation, but market participants are not buying that argument as the negative reaction to the news is evident with the SGX Nifty trading lower by 175 points and indicating Nifty opening below the 10,350 mark. Going ahead, market participants will keep a close eye on counting of five state election results.  

RSS
First31153116311731183120312231233124Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR